Rishon-LeZion, Israel

Gadi Pelled

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 116(Granted Patents)


Location History:

  • Rishon Leziyon, IL (2005 - 2009)
  • Jerusalem, IL (2012)
  • Rishon-LeZion, IL (2011 - 2016)

Company Filing History:


Years Active: 2005-2016

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Gadi Pelled - Revolutionizing Tissue Regeneration

Introduction: Gadi Pelled, a prominent inventor based in Rishon-LeZion, IL, is known for his groundbreaking work in the field of tissue regeneration. With a remarkable track record of 5 patents under his belt, Pelled continues to push the boundaries of innovation in healthcare.

Latest Patents: Among his latest patents is the development of "Scaffolds with oxygen carriers, and their use in tissue regeneration." These fibrin or silk matrices, integrated with oxygen carriers and mesenchymal stem cells, offer novel methods for ex vivo or in vivo tissue regeneration. Applications include treating non-union bone fractures and conditions requiring spinal fusion. Additionally, Pelled introduced "Composite scaffolds and methods using same for generating complex tissue grafts," highlighting his commitment to engineering heterogeneous tissues efficiently.

Career Highlights: Pelled has notably contributed his expertise to esteemed organizations such as Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Gesellschaft Fuer Biotechnologische Forschung Mbh. His dedication to advancing regenerative medicine underscores his impact on the industry.

Collaborations: Throughout his career, Pelled has collaborated with accomplished professionals, including Dan Gazit and Gadi Turgeman. These collaborations have enhanced the scope and impact of his research, fostering a culture of innovation and excellence.

Conclusion: Gadi Pelled's innovative contributions in tissue regeneration exemplify his commitment to improving healthcare outcomes. With a strong foundation in patented technologies and strategic collaborations, Pelled continues to drive forward the future of regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…